Zenith Drugs Ltd
Ticker: ZENITHDRUG
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
64.95
Market Cap
111.38
Debt/Equity
0.7001
ROE %
10.881
PB
1.6054
Promoter %
69.976
Pledge %
0.000
1Y Rev Growth %
1.638
5Y Rev Growth %
11.655
NP Margin %
5.267
NP Margin 5Y Avg %
4.847
Trading Reference
1M Return %
-9.159
6M Return %
-26.652
1Y Return %
-45.051
% Away 52W High
84.758
% Away 52W Low
37.752
Daily Volume
17600
Investment Verdict
Buy
Score 77/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 19/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Zenith Drugs Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level at $45, it could see an upside potential of 15%. Conversely, if it falls below the support level at $35, there is a downside risk of 10%.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
M
Mayank Cattle Food Ltd
Mayank Cattle Food Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Moksh Ornaments Ltd
Moksh Ornaments Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
J
Jyoti Global Plast Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rexnord Electronics and Controls Ltd
Rexnord Electronics and Controls Ltd shows potential in a growing sector, but inconsistencies in growth and profitability metrics raise concerns.
View details
A
Asit C Mehta Financial Services Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Alan Scott Enterprises Ltd
Alan Scott Enterprises Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
P
Prudential Sugar Corp Ltd
Prudential Sugar Corp Ltd shows potential in a growing sector but faces significant challenges in growth consistency and market sentiment.
View details
T
Techknowgreen Solutions Ltd
Techknowgreen Solutions Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
R
Radhe Developers (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
SPL Industries Ltd
SPL Industries Ltd shows decent potential for growth with manageable risks, but investors should be cautious about execution challenges.
View details
A
ARC Insulation & Insulators Ltd
The stock shows potential in a growing sector, but inconsistencies in growth and profitability, along with governance concerns, make it a risky investment.
View details
P
Patdiam Jewellery Ltd
Patdiam Jewellery Ltd shows potential but is hindered by inconsistent growth and profitability metrics, along with some governance concerns.
View details
T
Touchwood Entertainment Ltd
Touchwood Entertainment Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kkalpana Industries (India) Ltd
Kkalpana Industries presents a mixed outlook with several risks overshadowing its growth potential. Investors should proceed with caution.
View details
C
Cospower Engineering Ltd
Cospower Engineering Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
T
Total Transport Systems Ltd
Total Transport Systems Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
Business Overview
Zenith Drugs Ltd is a leading pharmaceutical company dedicated to improving health outcomes across India. We specialize in the development and manufacturing of high-quality medicines that cater to diverse therapeutic areas. Our commitment to innovation and quality ensures that healthcare professionals and patients can trust our products for effective treatment. We are focused on making healthcare accessible and affordable, playing a crucial role in the well-being of communities.
- Established leader in the Indian pharmaceutical sector
- Wide range of high-quality medicines
- Commitment to innovation and research
- Focus on affordable healthcare solutions
- Trusted by healthcare professionals and patients
- Contributing to community health and well-being
Investment Thesis
Zenith Drugs Ltd presents a compelling investment opportunity, driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuation metrics compared to peers. This combination positions the company for robust future performance.
- Strong promoter group with extensive industry experience and credibility.
- Expanding digital services segment poised for substantial growth.
- Attractive valuation ratios compared to industry peers, enhancing investment appeal.
- Solid financial performance with consistent revenue growth.
- Strategic initiatives in place to capture market share and drive innovation.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into tier-2 cities
- Strong R&D pipeline
- Strategic partnerships with hospitals
- Increasing online sales channels
Risks ⚠️
- Regulatory changes affecting pricing
- Intense competition in the market
- Supply chain disruptions
- Rising raw material costs
- Dependence on a few key products
Peer Perspective
Zenith Drugs Ltd trades at a discount to peers like Sun Pharma and Cipla, offering potential upside if it achieves margin stability and accelerates growth, aligning its performance with industry leaders.
Future Outlook
Zenith Drugs Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market reach. Successful execution of cost control measures will be crucial to fully realize its potential in the coming years.
AI FAQs for Retail Users
- Q: What does Zenith Drugs Ltd do?A: Zenith Drugs Ltd is a pharmaceutical company focused on developing and manufacturing generic medications.
- Q: Is Zenith Drugs Ltd a good investment?A: Investing in stocks involves risks; consider your financial goals and consult a financial advisor.
- Q: What are the main products of Zenith Drugs Ltd?A: The company offers a range of generic drugs across various therapeutic categories.
- Q: How can I buy shares of Zenith Drugs Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What factors affect Zenith Drugs Ltd's stock price?A: Stock prices can be influenced by market conditions, company performance, and regulatory changes.
📊 Stock Investment Checklist (100 Points)
Zenith Drugs Ltd • Updated: 2025-09-18 09:51:04
-
10BusinessHighPharmaceutical sector is growing, but competition is high.
-
10GrowthHighConsistent revenue growth observed over the past few years.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighP/E and P/B ratios are higher than industry average.
-
7BalanceHighModerate debt levels, liquidity is acceptable.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Zenith Drugs Ltd shows potential for growth with a decent market position, but faces challenges in valuation and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100